Science
MinutePhrase
•
Now
•
100%
CRISPR-Cas9 gene editing successful for a patient with Sickle Cell Disease and another patient with transfusion dependent β-Thalassemia - More than a year later, both patients had clinically improved
www.nejm.orgComments 0